MDC1 and neoplasm: To further investigate whether the PARPi resistance can be recapitulated in vivo, we expressed the non-targeting (NT) or Mdc1-targeting gRNAs in the KB2P tumor-derived organoids and grafted them orthotopically into a mammary gland of mice as described previously [23].